Navigation Links
Regeneron Reports Full Year and Fourth Quarter 2010 Financial and Operating Results
Date:2/17/2011

p>

Based on these positive results, Regeneron and Bayer Healthcare are discussing plans to initiate Phase 3 studies of VEGF Trap-Eye in DME.

Phase 3 study in choroidal neovascularisation

In January 2011, Regeneron and Bayer HealthCare announced a new Phase 3 clinical trial in Asia in collaboration with the Singapore Eye Research Institute (SERI) investigating the efficacy and safety of VEGF Trap-Eye in patients with choroidal neovascularisation (CNV) of the retina as a result of pathologic myopia.

ARCALYST® (rilonacept)– GoutARCALYST® is a fusion protein that blocks the cytokine interleukin-1 (IL-1).  ARCALYST® is currently available for prescription in the United States for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Auto-inflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS) in adults and children 12 and older.  CAPS is a group of rare, inherited, auto-inflammatory conditions characterized by life-long, recurrent symptoms of rash, fever/chills, joint pain, eye redness/pain, and fatigue.

ARCALYST® is in a Phase 3 clinical development program for the prevention of gout flares in patients initiating uric acid-lowering therapy.  In June 2010, the Company announced positive efficacy and safety results from a Phase 3 study (PRE-SURGE 1) in gout patients initiating allopurinol therapy to lower their uric acid levels.  Patients who received ARCALYST® at a weekly, self-administered, subcutaneous dose of 160 mg had an 80% decrease in mean number of gout flares compared to the placebo group over the 16 week treatment period (0.21 flares vs. 1.06 flares, p<0.0001).  Patients who received ARCALYST® at a weekly dose of 80 mg had a 73% decrease compared to the placebo group (0.29 flares vs. 1.06 flares, p<0.0001).  ARCALYST® was generally well tolerated with no reported drug-related serious adverse event
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
2. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
3. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
4. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
5. Regeneron Reports Third Quarter 2009 Financial and Operating Results
6. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
7. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
8. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
9. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
10. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
11. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... OTTAWA , Sept. 20, 2014 /CNW/ - The issue: ... voluntarily recalling all lots of its Mylan-Nitro Spray 0.4 mg/metered ... is part of the pump component. A ... delivery of nitroglycerin to the patient. This defect may lead ... fact they are unable to access it. Not receiving nitroglycerin ...
(Date:9/19/2014)... HILL, N.C. , Sept. 19, 2014 /PRNewswire/ ... role in forging relationships with key opinion leaders ... market and competition. Despite the critical nature of ... created many challenges, including altering the landscape for ... According to research, the oversight responsibility ...
(Date:9/19/2014)... , Sept. 19, 2014 Harwood Feffer LLP ... board of directors of PDL BioPharma, Inc. ("PDL" or ... the board has breached its fiduciary duties to shareholders ... September 16, 2014, the Company disclosed: "On September 11, ... accounting firm, Ernst & Young LLP ("EY"), that it ...
Breaking Medicine Technology:Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2Role of Medical Science Liaisons Shifting in Healthcare Industry 2Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2
(Date:9/21/2014)... Texas (PRWEB) September 21, 2014 ... (FDA) in 1996, GSK’s Flovent (fluticasone propionate) is ... It is used for the maintenance treatment of ... now available in two formulations, Diskus and HFA, ... 2004, respectively. Flovent’s active ingredient, fluticasone propionate, can ...
(Date:9/21/2014)... September 21, 2014 High in the ... of disabled and able-bodied athletes rafted the Colorado River, ... ropes course in pursuit of outdoor adventure. At the ... non-profit World T.E.A.M. Sports, disabilities proved to be no ... completed the three stage event. , Each participating team ...
(Date:9/21/2014)... 21, 2014 “Cluster headaches are sometimes ... and difficult to resolve,” said Steve Young of Ew ... of a pain that is more intense.” , “It ... cluster headaches, or migraines, that medical research is pointing ... system,” he added. , Serotonin (5-HT, 5-hydroxytryptamine) is a ...
(Date:9/21/2014)... Owings Mills, Md. (PRWEB) September 21, 2014 ... K-12 school with a coed preschool in Owings Mills, Md., ... toward wellness with Garmin Vivofit bands. GFS is the first ... like steps taken, calories burned and even sleep patterns— as ... , a Baltimore area running and walking specialty chain. The ...
(Date:9/21/2014)... Top10BestSEOHosting.com, a leading review website, has recently announced ... most recommended hosting suppliers for the webmasters worldwide ... , “Don’t waste your time on searching ... hosting companies to you,” the IT manager of ... are the most recommended suppliers for everyone. A ...
Breaking Medicine News(10 mins):Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 2Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 3Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:Garrison Forest School Leader in Independent School Wellness Programs 2Health News:Leading Review Website Top10BestSEOHosting.com Unveils The Best Hosting Suppliers In September 2
... Terry releases video statement for Pro-life leaders concerning Dr. ... , WASHINGTON, May 31 The following was ... Background: In 1991, Mr. Terry was arrested by federal ... part in leading the "Summer of Mercy." Mr. Terry,s ...
... patient-tailored approaches may work for skin, stomach and other ... News) -- In a new study, patients with ... their own cancer cells went more than 44 months ... who didn,t get the vaccine. , The vaccine trial ...
... that the first clinical series using the SlimLine GI ... Chicago May 30-June 4th entitled:Holmium-YAG Laser Lithotripsy in the ... Cholangioscopy (SPYGLASS): a Multi-Center Experience. The presentation reports on ... and impacted stones in 18 of the 31 patients. ...
... The American Society for Gastrointestinal Endoscopy (ASGE) will honor important ... ASGE Crystal Awards on Sunday, May 31. Hosted by ASGE ... 6:30 p.m. at Navy Pier in Chicago. , Held ... Awards symbolize the finest in leadership, research and scientific pursuit. ...
... Impac Software joined the National Cancer Registrars Association,s (NCRA) ... of the Seventh Annual Impac Software-JRM Best Paper Award. ... official journal of the NCRA, partnered on this award ... registry field throughout 2008. The awards were ...
... menstruating, supplements boost vascular function, study finds , , ... acid supplementation improved vascular function in young female ... intake was lower than their energy output, researchers ... may decrease cardiovascular risk and also improve performance ...
Cached Medicine News:Health News:'Dr. Tiller was a mass murderer; states Randall Terry. 'We must not flinch or waver in our rhetoric or our actions.' 2Health News:Immune-Based Lymphoma Treatment Shows Promise 2Health News:Immune-Based Lymphoma Treatment Shows Promise 3Health News:Immune-Based Lymphoma Treatment Shows Promise 4Health News:Immune-Based Lymphoma Treatment Shows Promise 5Health News:Lumenis(R) Presents the SlimLine(TM) GI Laser Fiber: The Latest Advancement in Laser Lithotripsy for Gastroenterology 2Health News:Lumenis(R) Presents the SlimLine(TM) GI Laser Fiber: The Latest Advancement in Laser Lithotripsy for Gastroenterology 3Health News:Lumenis(R) Presents the SlimLine(TM) GI Laser Fiber: The Latest Advancement in Laser Lithotripsy for Gastroenterology 4Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 2Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 3Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 4Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 5Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 6Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 7Health News:National Cancer Registrars Association and Impac Software Announce Best Paper Award Recipients 2Health News:Women Who Run May Benefit From Extra Folic Acid 2
... to use, the Gel XL Ultra includes all ... The unit is compact, requiring a minimal amount ... a tangled mess of leads and cords on ... and convenience, the power supply can detect when ...
... has a centimeter ruler etched into the gel ... It includes apparatus, connecting cables, three 7x10 cm ... and three 14-well combs. The Chameleon can accomodate ... electrophoresis of a maximum of 120 samples with ...
... (patented) provides unparalleled reproducibility, speed and convenience ... combination with Elchrom Scientific AG ready-to-use gels ... a regular submarine plus a vertical or ... it is possible to get the best ...
... gels offer many advantages for nucleic acid ... for the molecular biologist. Agarose gels are ... These gels allow sample underlaying and prevent ... sample well dehydration. Horizontal systems are more ...
Medicine Products: